On Tuesday, Perspective Therapeutics Inc (AMEX: CATX) opened lower -4.44% from the last session, before settling in for the closing price of $3.83. Price fluctuations for CATX have ranged from $2.70 to $19.05 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 49.34% at the time writing. With a float of $48.92 million, this company’s outstanding shares have now reached $67.56 million.
Let’s determine the extent of company efficiency that accounts for 119 employees. In terms of profitability, gross margin is 100.0%, operating margin of -15937.09%, and the pretax margin is -13973.89%.
Perspective Therapeutics Inc (CATX) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Perspective Therapeutics Inc is 27.62%, while institutional ownership is 75.77%. The most recent insider transaction that took place on Dec 04 ’24, was worth 100,004. In this transaction Director of this company bought 25,975 shares at a rate of $3.85, taking the stock ownership to the 25,975 shares. Before that another transaction happened on Dec 04 ’24, when Company’s CEO bought 8,000 for $3.77, making the entire transaction worth $30,132. This insider now owns 36,257 shares in total.
Perspective Therapeutics Inc (CATX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 49.34% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.82% during the next five years compared to -7.69% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Check out the current performance indicators for Perspective Therapeutics Inc (CATX). In the past quarter, the stock posted a quick ratio of 9.60.
Technical Analysis of Perspective Therapeutics Inc (CATX)
Looking closely at Perspective Therapeutics Inc (AMEX: CATX), its last 5-days average volume was 1.18 million, which is a drop from its year-to-date volume of 1.19 million. As of the previous 9 days, the stock’s Stochastic %D was 66.67%. Additionally, its Average True Range was 0.34.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 7.05%, which indicates a significant decrease from 52.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.84% in the past 14 days, which was lower than the 139.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.02, while its 200-day Moving Average is $11.14. However, in the short run, Perspective Therapeutics Inc’s stock first resistance to watch stands at $3.91. Second resistance stands at $4.16. The third major resistance level sits at $4.34. If the price goes on to break the first support level at $3.49, it is likely to go to the next support level at $3.31. Should the price break the second support level, the third support level stands at $3.06.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
There are currently 67,588K shares outstanding in the company with a market cap of 247.37 million. Presently, the company’s annual sales total 1,430 K according to its annual income of -46,510 K. Last quarter, the company’s sales amounted to 370 K and its income totaled -15,120 K.
